When we launched Foley’s inaugural Telemedicine and Digital Health Survey in 2014, it was apparent that health care executives weren’t ready to make telemedicine a significant focus of their business and patient strategies. The interest was there but, despite tremendous technological breakthroughs and imaginative applications, most telemedicine programs were in the early stages and there
When we launched Foley’s inaugural Telemedicine and Digital Health Survey in 2014, it was apparent that health care executives weren’t ready to make telemedicine a significant focus of their business and patient strategies. The interest was there but, despite tremendous technological breakthroughs and imaginative applications, most telemedicine programs were in the early stages and there was little acceptance by the broader health care community.
Fast forward to present time and the industry outlook has changed dramatically, due in large part to proven patient outcomes and surging demand among providers looking to improve the quality of care in a more convenient, cost-effective manner.
According to our 2017 survey, where we queried a range of executives at hospitals, specialty clinics, ancillary services and related organizations, three-quarters of respondents currently offer, or are planning to provide, telemedicine services. Now, compare that to three years ago when nearly 87 percent didn’t expect their patients to be using telemedicine services by this time – that’s quite a turnaround.
Beyond adoption, providers reported strong satisfaction with the telemedicine platforms they were using; over half of the organizations that track return on investment reported savings of 10 percent or more. And, a third of respondents said 50 percent or more of patients continued to use telemedicine after an initial visit, demonstrating growing patient satisfaction with the service.
The deluge of telemedicine programs entering the mature and implementation phases doesn’t come without complications, however. Providers are already looking to expand their telemedicine programs overseas, where they’ll encounter unfamiliar governance in foreign jurisdictions. Furthermore, there’s still more work to be done here in the United States, where the Food and Drug Administration needs to weigh in on new software and other digital health technologies, and state and federal governments must reduce regulatory ambiguities and barriers.
These complex issues can and should be considered great opportunities for the health care industry’s major players. Those that are able to navigate new and existing laws and regulations will better positioned to take advantage of the rapid advancements in technology which, in turn, will enable them to provide innovative care for patients in new markets around the block and around the world.
To read more about these key themes and others that emerged in our research, please visit http://bit.ly/Foley-Telemedicine-Survey.
This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney.
This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary.
The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites.
In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.
All copyrights for this article are reserved to Telehealth Law